for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Athenex Inc

ATNX.O

Latest Trade

11.05USD

Change

-0.19(-1.69%)

Volume

77,479

Today's Range

11.03

 - 

11.27

52 Week Range

5.63

 - 

19.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Officers & DirectorsAs of

NameAgePositionAppointed
Johnson Y.N. Lau
Chief Executive Officer and Chairman of the Board
59Chief Executive Officer and Chairman of the Board2011
Randoll Sze
Chief Financial Officer
39Chief Financial Officer2018
William W. Zuo
President, China Division
58President, China Division2015
Jeffrey M. Yordon
Chief Operating Officer and President, Athenex Pharmaceutical Division
71Chief Operating Officer and President, Athenex Pharmaceutical Division2017
Daniel Lang
Senior Director - Corporate Development, President - Axis Therapeutics Limited
--Senior Director - Corporate Development, President - Axis Therapeutics Limited2019
Rudolf Kwan
Chief Medical Officer
67Chief Medical Officer2014
Simon C. Pedder
Chief Business and Strategy Officer - Proprietary Products
59Chief Business and Strategy Officer - Proprietary Products2019
Kim Campbell
Lead Independent Director
73Lead Independent Director2015
Manson Fok
Director
63Director2015
Stephanie A. Davis
Independent Director
56Independent Director2019
Jordan S. Kanfer
Independent Director
50Independent Director2019
John Tiong Lu Koh
Independent Director
64Independent Director2019
Benson Kwan Hung Tsang
Independent Director
55Independent Director2018
John Moore Vierling
Independent Director
74Independent Director2019
Jinn Wu
Independent Director
71Independent Director2007

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up